$XBI $150.78 (-2.17%) 📉
COVID:
$VBIV (-6.53%) - VBI Vaccines Announces Progress of Coronavirus Vaccine Program
$MRNA (+6.26%) - Moderna Announces First Participant Dosed in Phase 1/2 Study of Moderna COVID-19 Vaccine in Japan Led by Takeda
PIPELINE:
$INMB (-18.95%) - INmune Bio, Inc. Announces XPro1595 Found to Decrease Neuroinflammation and Neurodegeneration Biomarkers in Patients with Alzheimer’s Disease in Phase 1b Trial
$AMRN (+1.77%) - ICOSAPENT ETHYL INCLUDED IN THE CHINESE SOCIETY OF CARDIOLOGY (CSC) UPDATED GUIDELINES FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASES
$ORMP (+6.26%) - Oramed Doses Patients Across Multiple Sites in Phase 3 Oral Insulin Study
$CDAK (-5.41%) - Codiak’s Versatile engEx™ Platform for Engineered Exosomes Published in the Journal Molecular Therapy
$HTRX (+0.11%) - Heron Therapeutics Announces Publication of Results from EPOCH 1 Follow-On Study of HTX-011 in Patients Undergoing Bunionectomy Surgery
$SPRO (+3.14%) - Spero Therapeutics Announces Issuance of Allowance for a U.S. Patent Covering Lead Candidate Tebipenem HBr
FINANCIAL:
$EDIT (-11.11%) - Pricing of an underwritten offering of 3,500,000 shares of its common stock at a public offering price of $66.00 per share
$PGEN (-2.87%) - Precigen Announces Proposed Public Offering of Common Stock
$MRUS (+8.75%) - Pricing of an underwritten public offering of 4,848,485 common shares at a public offering price of $24.75 per share.
$ONCS (+23.09%) - Pricing of an underwritten public offering of 7,711,284 shares of its common stock at a price of $5.45 per share